X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PROCTER & GAMBLE HEALTH    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   ADCOCK INGRAM
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
ADCOCK INGRAM
Jun-14
PROCTER & GAMBLE HEALTH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,358357-   
Low Rs933258-   
Sales per share (Unadj.) Rs665.0106.3-  
Earnings per share (Unadj.) Rs56.6-26.8-  
Cash flow per share (Unadj.) Rs72.5-22.2-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.783.5-  
Shares outstanding (eoy) m16.60168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.9 59.5%   
Avg P/E ratio x20.2-11.5 -176.3%  
P/CF ratio (eoy) x15.8-13.9 -114.0%  
Price / Book Value ratio x2.63.7 70.3%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,01151,922 36.6%   
No. of employees `0001.54.3 36.0%   
Total wages/salary Rs m1,6963,259 52.1%   
Avg. sales/employee Rs Th7,150.04,180.1 171.0%   
Avg. wages/employee Rs Th1,098.7759.1 144.7%   
Avg. net profit/employee Rs Th608.2-1,053.3 -57.7%   
INCOME DATA
Net Sales Rs m11,04017,945 61.5%  
Other income Rs m240126 190.7%   
Total revenues Rs m11,27918,071 62.4%   
Gross profit Rs m1,376-3,110 -44.3%  
Depreciation Rs m264775 34.1%   
Interest Rs m0486 0.0%   
Profit before tax Rs m1,352-4,245 -31.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m583265 219.7%   
Profit after tax Rs m939-4,522 -20.8%  
Gross profit margin %12.5-17.3 -71.9%  
Effective tax rate %43.1-6.2 -689.9%   
Net profit margin %8.5-25.2 -33.8%  
BALANCE SHEET DATA
Current assets Rs m7,52313,143 57.2%   
Current liabilities Rs m2,2537,395 30.5%   
Net working cap to sales %47.732.0 149.0%  
Current ratio x3.31.8 187.9%  
Inventory Days Days52111 47.0%  
Debtors Days Days41124 32.7%  
Net fixed assets Rs m1,2407,661 16.2%   
Share capital Rs m16683 199.2%   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,33314,085 52.1%   
Long term debt Rs m04,950 0.0%   
Total assets Rs m9,91226,608 37.3%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.7 165.1%   
Return on assets %9.5-15.2 -62.5%  
Return on equity %12.8-32.1 -39.9%  
Return on capital %20.8-19.8 -104.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m5371,532 35.0%  
From Investments Rs m-476-470 101.3%  
From Financial Activity Rs m-2204,492 -4.9%  
Net Cashflow Rs m-1605,554 -2.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare PROCTER & GAMBLE HEALTH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PROCTER & GAMBLE HEALTH With: ALEMBIC LTD  UNICHEM LAB  PLETHICO PHARMA  WYETH LTD  CIPLA  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views On News

PROCTER & GAMBLE HEALTH at All Time High; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Jul 16, 2019 | Updated on Jul 16, 2019

PROCTER & GAMBLE HEALTH share price has hit an all time high at Rs 4,768 (up 9.3%). The BSE HEALTHCARE Index is up by 0.9%. Among the top gainers in the BSE HEALTHCARE Index today are PROCTER & GAMBLE HEALTH (up 9.3%) and SANOFI INDIA (up 0.5%). The top losers include BLISS GVS PHARMA (down 0.2%) and NARAYANA HRUDAYALAYA LTD (down 0.2%).

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today (Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 16, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS